Lipid metabolism disorders and thyrotoxicosis
D. I. Sadykova,
A. V. Susekov,
I. V. Leontyeva,
I. I. Zakirov,
E. S. Slastnikova,
L. F. Galimova,
D. R. Sabirova,
N. V. Krinitskaya https://doi.org/10.21508/1027-4065-2020-65-6-91-97
Abstract
Disorders of lipid metabolism in endocrine diseases are a frequent occurrence in the daily practice of a doctor and usually have secondary nature. In thyrotoxicosis they have normal or decreased level of total cholesterol and low-density lipoproteins. A clinical case of a patient with thyrotoxicosis, hypercholesterolemia and hypertriglyceridemia is presented. The clinical and laboratory results of the study of the child and his parents are presented. DNA testing was conducted to clarify the diagnosis and conduct differential diagnosis of dyslipidemia type. This case shows difficulties in the diagnostic search for the etiology of dyslipidemia and its correction.
About the Authors
D. I. Sadykova
Kazan State Medical University
Russian Federation
Kazan
Russian Federation
Kazan
A. V. Susekov
National Medical Research Center of Cardiology
Russian Federation
Moscow
Russian Federation
Moscow
I. V. Leontyeva
Veltischev Research and Clinical Institute for Pediatrics at the Pirogov Russian National Research Medical University
Russian Federation
Moscow
Russian Federation
Moscow
I. I. Zakirov
Children’s Republican Clinical Hospital
Russian Federation
Kazan
Russian Federation
Kazan
E. S. Slastnikova
Kazan State Medical University; Children’s Republican Clinical Hospital
Russian Federation
Kazan
Russian Federation
Kazan
L. F. Galimova
National Medical Research Center of Cardiology
Russian Federation
Moscow
Russian Federation
Moscow
D. R. Sabirova
Kazan State Medical University
Russian Federation
Kazan
Russian Federation
Kazan
N. V. Krinitskaya
National Medical Research Center of Cardiology
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Fredrickson D.S., Lees R.S. A system for phenotyping hyperlipoproteinemia. Circulation 1965; 31:321–327. DOI: 10.1161/01.cir.31.3.321
2. Tremblay K., Gaudet D., Khoury E., Brisson D. Dissection of Clinical and Gene Expression Signatures of Familial versus Multifactorial Chylomicronemia. J Endocrine Soc 2020; 4(6): bvaa056, DOI: 10.1210/jendso/bvaa056
3. Moulin P., Dufour R., Averna M., Arca M., Cefalù A.B., Noto D. et al. Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an “FCS score”. Atherosclerosis 2018; 275: 265–272. DOI: 10.1016/j.atherosclerosis.2018.06.814
4. Rizos C.V., Elisaf M.S., Liberopoulos E.N. Effects of Thyroid Dysfunction on Lipid Profile. Open Cardiovasc Med J 2011; 5: 76–84. DOI: 10.2174/1874192401105010076
5. Трошина Е.А., Свириденко Н.Ю., Ванушко В.Э., Румянцев П.О., Фадеев В.В., Петунина Н.А. и др. Федеральные клинические рекомендации по диагностике и лечению токсического зоба Проблемы эндокринологии 2014;60(6): 67–77. [Troshina E.A., Sviridenko N.Yu., Vanushko V.Je., Rumyantsev P.O., Fadeev V.V., Petunina N.A. et al. The federal clinical recommendations on diagnostics and treatment of toxic goiter. Problemy endokrinologii 2014; 60(6): 67–77. (in Russ.)] DOI: 10.14341/probl201460667-77
6. Безлер Ж.А., Войтович Т Н. Гипертиреоз у детей: учеб.- метод. пособие. Минск: БГМУ, 2017; 31. [Bezler Zh.A., Vojtovich T.N. Hyperthyroidism in children: a study guide. Minsk: BGMU, 2017; 31. (in Russ.)]
7. Mach F., Baigent C., Catapano A.L., Koskinas K.C., Casula M., Badimon L., et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020; 41(1): 111–188. DOI: 10.1093/eurheartj/ehz455
8. Raal F.J. The cardioprotective diet: carbohydrates versus fat. Cardiovasc J Africa 2014; 25(6): 302. DOI: 10.5830/CVJA-2014-063
9. Ewald N., Hardt P.D., Kloer H.-Ul. Severe hypertriglyceridemia and pancreatitis: presentation and management. Curr Opin Lipidol 2009; 20: 497–504. DOI: 10.1097/MOL.0b013e3283319a1d
10. едеральные клинические рекомендации (протоколы) по ведению детей с эндокринными заболеваниями. Под ред. И.И. Дедова и В.А. Петерковой. М.: Практика, 2014; 442. [Federal clinical guidelines (protocols) on the management of children with endocrine diseases. I.I. Dedov, V.A. Peterkova (eds). Moscow: Praktika, 2014; 442. (in Russ.)]
11. Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. Российские рекомендации. V пересмотр. Атеросклероз и дислипидемии 2012; 4(9): 4–52. [Diagnostics and correction of lipid metabolism disorders in order to prevent and treat atherosclerosis. Russian recommendations. V revision. Ateroskleroz i dislipidemii 2012; 4(9): 4–52. (in Russ.)]
12. Ежов М.В., Близнюк С.А., Тмоян Н.А. Регистр пациентов с семейной гиперхолестеринемией и пациентов очень высокого сердечно-сосудистого риска с недостаточной эффективностью, проводимой гиполипидемической терапии (РЕНЕССАНС). Российский кардиологический журнал 2019; 24(5): 7–13. [Ezhov M.V., Bliznjuk S.A., TmojanN.A.Registry of patients with familial hypercholesterolemia and patients of very high cardiovascular risk with insufficient effectiveness of lipid-lowering therapy (RENAISSANCE). Rossiiskii kardiologicheskii zhurnal 2019; 24(5): 7–13. (in Russ.)] DOI: 10.15829/1560-4071-2019-5-7-13
Review
For citations:
Sadykova D.I., Susekov A.V., Leontyeva I.V., Zakirov I.I., Slastnikova E.S., Galimova L.F., Sabirova D.R., Krinitskaya N.V. Lipid metabolism disorders and thyrotoxicosis. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2020;65(6):91-97. (In Russ.) https://doi.org/10.21508/1027-4065-2020-65-6-91-97
Views:
1452
Email this article 